Description: PharmChem, Inc. is a provider of the PharmChek Sweat Patch, which is used to detect drugs of abuse. The PharmChek Sweat Drugs of Abuse Detection Patch screens marijuana, cocaine, opiates, amphetamine/methamphetamine and phencyclidine (PCP). The PharmChek Sweat Patch detects the drug metabolite and its parent drug (instant urine tests detect only the metabolite); cannot be diluted; can be worn around the clock, 7 to 10 days of continuous wear time; acts as a deterrent to additional drug use; is tamper-evident, and gender indifferent. The Company's drugs of abuse patch uses sweat as the specimen source. The Company's product line includes 50 Patch Commercial Kit and 10 Patch Commercial Kit. The Sweat Patch Specimen Container for Collection is a Class I and II Device, and is a non-invasive tool, which collects excreted sweat for testing in clinical trials and research studies.
Home Page: www.pharmchek.com
2411 East Loop 820 North
Fort Worth,
TX
76118
United States
Phone:
855-458-4100
Officers
| Name | Title |
|---|---|
| Matt Katz | Chief Exec. Officer |
| Shana Veale | CFO, VP & Controller |
| Kerri Wagner | Chief Revenue Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0019 |
| Price-to-Sales TTM: | 0.0006 |
| IPO Date: | 1991-08-08 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |